BUSINESSDESK: A2 Corp, which markets milk products with a protein variant claimed to have health benefits, wants to directly enter the New Zealand market and is looking to expand into North America and some European nations after undertaking a strategic review to speed up growth.
The alternative-market listed company will shift its focus to a number of opportunities in a bid to ramp up growth, including directly marketing into New Zealand, it says in a statement.
A2 plans to expand rapidly include entering markets in North America, German, France Italy and Spain via joint ventures, using local contract manufacturers or investing in regional processing, it says.
Other plans include developing its suite of intellectual property and patents, and accelerating its existing investment in Britain and China. It is also looking at expanding its product range to ultra-heat tested (UHT) milk and yoghurt.
"A2 is well placed to drive strong future growth independent, with an openness to engage with potential partners who may assist with its global ambitions," the company says.
"By virtue of the capital light partnership model the company is well positioned to progressively fund its development through its internally generated cashflows and strong balance sheet."
The six-month review's results come a week after A2 entered into a Chinese distribution arrangement with China State Farm Holding Shanghai Company, a subsidiary of state-owned China National Agriculture Development Group Corp, as the exclusive distributor of its a2 brand infant formula.
The shares fell 1.5% to 67 cents, having surged 183% this year.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- UPDATED: Australia's Bapcor mounts $322.5m takeover bid for Hellaby
- Commerce Commission reveals the most complained-about companies
- Editor's Insight: How the candidates fared in the first presidential debate
- Where the polls stand on the eve of the first US presidential debate
- AngelEquity launches with three investment offers
Most listened to
- No knockout blows in first presidential debate, says NBR's Nevil Gibson
- Intueri's problems raise questions for the board, says Martin Watson of the Shareholders Association
- ANZ's Philip Borkin and NBR's Jason Walls on what's next for the kiwi dollar on Currency Talk
- AngelEquity's Bill Murphy on why his platform won't cater for retail investors
- Spark exec Jason Paris defends his company's honour after it tops ComCom's most-complained-about list
- FMA lawyer Justin Smith counters the Goldman Sachs defence